183 related articles for article (PubMed ID: 31776419)
1. Sema4C mediates EMT inducing chemotherapeutic resistance of miR-31-3p in cervical cancer cells.
Jing L; Bo W; Yourong F; Tian W; Shixuan W; Mingfu W
Sci Rep; 2019 Nov; 9(1):17727. PubMed ID: 31776419
[TBL] [Abstract][Full Text] [Related]
2. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.
Song J; Li Y
Cancer Sci; 2017 Jan; 108(1):23-31. PubMed ID: 27743413
[TBL] [Abstract][Full Text] [Related]
3. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
[TBL] [Abstract][Full Text] [Related]
4. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X; Zhang C; Tian Y
J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
[TBL] [Abstract][Full Text] [Related]
7. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
[TBL] [Abstract][Full Text] [Related]
8. MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.
Wang J; Liu L
J Ovarian Res; 2021 Nov; 14(1):165. PubMed ID: 34798882
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
10. MiR-377-3p inhibits cell metastasis and epithelial-mesenchymal transition in cervical carcinoma through targeting SGK3.
Zhang XY; Dong XM; Wang FP
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4687-4696. PubMed ID: 32432732
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.
Wei WF; Zhou CF; Wu XG; He LN; Wu LF; Chen XJ; Yan RM; Zhong M; Yu YH; Liang L; Wang W
Cell Death Dis; 2017 Dec; 8(12):3220. PubMed ID: 29242498
[TBL] [Abstract][Full Text] [Related]
12. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.
Niu Q; Liu Z; Gao J; Wang Q
Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.
Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W
J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360
[TBL] [Abstract][Full Text] [Related]
14. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
16. MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
Wang D; Wang H; Li Y; Li Q
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871972
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA
Fan MJ; Zou YH; He PJ; Zhang S; Sun XM; Li CZ
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092700
[TBL] [Abstract][Full Text] [Related]
18. MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition.
Tang Y; Wang Y; Chen Q; Qiu N; Zhao Y; You X
Int J Clin Exp Pathol; 2015; 8(9):11224-9. PubMed ID: 26617846
[TBL] [Abstract][Full Text] [Related]
19. microRNA-141-3p fosters the growth, invasion, and tumorigenesis of cervical cancer cells by targeting FOXA2.
Li JH; Zhang Z; Du MZ; Guan YC; Yao JN; Yu HY; Wang BJ; Wang XL; Wu SL; Li Z
Arch Biochem Biophys; 2018 Nov; 657():23-30. PubMed ID: 30222949
[TBL] [Abstract][Full Text] [Related]
20. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
